iCo Therapeutics to Present at BIO InvestorForum in San Francisco
VANCOUVER, Oct. 17 /PRNewswire/ - iCo Therapeutics Inc. announced today that Andrew Rae, iCo's Chief Executive Officer, will present at the BIO InvestorForum to be held October 19-20th, 2005 in San Francisco, California. Approximately 190 public and venture-stage companies are slated to present at this conference which is being hosted by the Biotechnology Industry Organization. Mr. Rae's presentation will take place on October 20th, 2005 at 12:20pm PST in the Sea Cliff room at the Palace Hotel in San Francisco. For more information about the conference, visit the BIO InvestorForum website at http://investorforum.bio.org/opencms/bif/2005/index.jsp. A live audio webcast of Mr. Rae's presentation will be available to all interested parties through a link posted on iCo's website at www.icotherapeutics.com. iCo seeks out and develops or modifies approved or near-approved therapies to treat a variety of conditions within isolated biological environments. Because the drugs have already been through extensive preclinical and clinical testing, and in some cases regulatory approval, development risk and time to commercialization is significantly decreased. iCo Therapeutics Inc. is an emerging, Vancouver-based biotechnology company focused on developing pre-existing drugs for a range of new conditions affecting isolated biological environments - areas such as the eye, spinal cord, or joints - where locally-administered application of these therapies would have minimal systemic distribution and fewer safety issues. For more information, visit the company website at: www.icotherapeutics.com Business Development Contact: Finance/Investor Contact: Dr. John Clement, CTO Mr. John Meekison, CFO 778.688.0644 604.602.9414 Media Contact: Elayne Wandler, ABCommunications 604.831.2506
SOURCE iCo Therapeutics Inc.
More by this Source
iCo Therapeutics Announces Final Eight Month Patient Visit in Phase 2 iDEAL Study
Mar 05, 2014, 07:00 ET
iCo Therapeutics Announces DTC Approval
Feb 25, 2014, 13:15 ET
iCo Therapeutics Inc. Completes C$6.75 Million Equity Financing
Jan 27, 2014, 10:03 ET
Browse our custom packages or build your own to meet your unique communications needs.
Learn about PR Newswire services
Request more information about PR Newswire products and services or call us at (888) 776-0942.